1. Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma
    Wahafu Alafate et al, 2020, CNS Neuroscience & Therapeutics CrossRef
  2. The Clinical Significance and Role of CXCL1 Chemokine in Gastrointestinal Cancers
    Jan Korbecki et al, 2023, Cells CrossRef

  3. Low-Dose Radiation Promotes Invasion and Migration of A549 Cells by Activating the CXCL1/NF-κB Signaling Pathway


    Jing Li et al, 2020, OncoTargets and Therapy CrossRef
  4. Identification of hub genes correlated with the pathogenesis and prognosis of gastric cancer via bioinformatics methods
    Kechao Nie et al, 2020, Minerva Medica CrossRef
  5. Comprehensive Analysis of Core Genes and Potential Mechanisms in Rectal Cancer
    Bao-Xinzi Liu et al, 2019, Journal of Computational Biology CrossRef
  6. OSlihc: An Online Prognostic Biomarker Analysis Tool for Hepatocellular Carcinoma
    Yang An et al, 2020, Frontiers in Pharmacology CrossRef
  7. Evaluation of CD44s, CD44v6, CXCR2, CXCL1, and IL-1β in Benign and Malignant Tumors of Salivary Glands
    Fonthip Laohavisudhi et al, 2022, Diagnostics CrossRef
  8. CXCL1 as an Unfavorable Prognosis Factor Negatively Regulated by DACH1 in Non-small Cell Lung Cancer
    Shengnan Yu et al, 2020, Frontiers in Oncology CrossRef
  9. A‐kinase interacting protein 1 might serve as a novel biomarker for worse prognosis through the interaction of chemokine (C‐X‐C motif) ligand 1/chemokine (C‐X‐C motif) ligand 2 in acute myeloid leukemia
    Xiaohong Hao et al, 2020, Journal of Clinical Laboratory Analysis CrossRef
  10. Prognostic and clinicopathological significance of CXCL1 in cancers: a systematic review and meta-analysis
    Zulei Zhang et al, 2019, Cancer Biology & Therapy CrossRef
  11. CXCL1: Gene, Promoter, Regulation of Expression, mRNA Stability, Regulation of Activity in the Intercellular Space
    Jan Korbecki et al, 2022, International Journal of Molecular Sciences CrossRef
  12. Plasma Levels of CXC Motif Chemokine 1 (CXCL1) and Chemokine 8 (CXCL8) as Diagnostic Biomarkers in Luminal A and B Breast Cancer
    Joanna Motyka et al, 2022, Journal of Clinical Medicine CrossRef
  13. CXCL1 stimulates migration and invasion in ER‑negative breast cancer cells via activation of the ERK/MMP2/9 signaling axis
    Chengcheng Yang et al, 2019, International Journal of Oncology CrossRef
  14. CXCL8 derived from tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression by promoting migration and invasion of cancer cells
    Masayoshi Hosono et al, 2017, Oncotarget CrossRef
  15. Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeutics
    Saumya Srivastava et al, 2022, Seminars in Cancer Biology CrossRef
  16. Analysis of the Prognosis and Therapeutic Value of the CXC Chemokine Family in Head and Neck Squamous Cell Carcinoma
    Yongchao Li et al, 2021, Frontiers in Oncology CrossRef
  17. Involvement of CXC chemokines (CXCL1-CXCL17) in gastric cancer: Prognosis and therapeutic molecules
    Amin Ullah et al, 2024, Life Sciences CrossRef